Invesco Ltd. - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 98 filers reported holding CYTOSORBENTS CORP in Q1 2021. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q1 2022$44,000
-26.7%
13,909
-2.3%
0.00%
Q4 2021$60,000
-49.6%
14,233
-2.8%
0.00%
Q3 2021$119,000
+43.4%
14,645
+32.6%
0.00%
Q2 2021$83,000
-39.0%
11,044
-29.1%
0.00%
Q1 2021$136,000
-35.5%
15,577
-44.0%
0.00%
Q1 2019$211,000
-18.5%
27,819
-13.4%
0.00%
Q4 2018$259,000
-91.0%
32,110
-85.5%
0.00%
-100.0%
Q3 2018$2,862,000
+710.8%
221,897
+617.5%
0.00%
Q2 2018$353,00030,9280.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Skylands Capital, LLC 815,869$3,141,0000.46%
Sargent Investment Group, LLC 499,010$1,921,0000.36%
Anson Funds Management LP 74,440$287,0000.33%
One68 Global Capital, LLC 39,241$151,0000.33%
Granahan Investment Management 678,618$2,613,0000.12%
Winning Points Advisors, LLC 30,000$115,0000.07%
Avenir Corp 150,600$580,0000.06%
HighMark Wealth Management LLC 10,000$38,0000.04%
Wealthcare Advisory Partners LLC 62,279$240,0000.03%
GSA CAPITAL PARTNERS LLP 64,970$250,0000.03%
View complete list of CYTOSORBENTS CORP shareholders